-
New collaboration will enhance ability to identify those more at risk of developing brain diseases to enable earlier interventions
Feb 28, 2024
-
Feb 20, 2024
-
Feb 17, 2024
-
Paving the way to advance cancer research and diagnosis with enriched, high-quality DICOM images
Feb 26, 2024
-
Feb 13, 2024
-
Feb 27, 2024
-
PathAI, Inc., a leading AI-powered precision pathology company, today announced the availability of two new features on the AISight digital pathology image management system – an Intelligent Caselist and AISight Live.
Feb 26, 2024
-
Feb 25, 2024
-
Feb 25, 2024
-
Feb 19, 2024
-
Feb 6, 2024
-
Huateng Pharma, a leading provider of high-quality pharmaceutical intermediates, is proud to unveil its latest breakthrough product: Semaglutide Side Chain. This innovative addition to Huateng Pharma's portfolio represents a significant milestone in pharmaceutical innovation, offering a range of compounds including AEEA-AEEA (CAS NO.: 1143516-05-5), SNAC (CAS NO.: 203787-91-1), tBuO-Ste-Glu(AEEA-AEEA)-OtBu (CAS NO.:1118767-16-0), and Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH (CAS NO.: 1662688-20-1).
Feb 22, 2024
-
Feb 13, 2024
-
Feb 6, 2024
-
Feb 22, 2024
-
Feb 22, 2024
-
Feb 21, 2024
-
Biotium has announced the expansion of its NucSpot® Nuclear Stains lineup, offering unprecedented specificity and flexibility for nuclear counterstaining.
Feb 20, 2024
-
ENPICOM has announced a collaboration with Erasmus Medical Center. This partnership aims to identify and develop nanobodies against cancer by utilizing ENPICOM’s immune repertoire data analysis services and software solutions.
Feb 19, 2024
-
Horizon CME has announced its sponsorship of the first annual summit for the multidisciplinary conference, Novel Therapeutics in Oncology & Precision Medicine in Cancer (STOP Cancer).
Feb 19, 2024